Ask AI
ProCE Banner Series

Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses

Key Takeaways

  • Review the underlying pathogenesis and associated manifestations of chronic graft-versus-host disease (cGVHD)
  • Understand how CSF-1R–dependent monocytes and macrophages contribute to the multiorgan inflammation and fibrosis that drive cGVHD
  • Evaluate the clinical trial data for Niktimvo™ (axatilimab-csfr) in patients with steroid-refractory cGVHD

All Events

Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses

Upcoming Events

October

01

2025

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

October

29

2025

12:15 PM - 1:15 PM Eastern Time (ET)

Virtual

Acknowledgement

Sponsored By

Incyte

Incyte